SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER

西南肿瘤组是一个主要的多疾病，多， 从事癌症合作的多学科、多机构小组 research. 该组织目前由33个成员机构组成， 社区临床肿瘤学项目（CCOPs），311合作小组 外展计划（CGOP），31泌尿系癌症外展计划（UCOP）， 和22个高优先级分支机构，他们总共积累了6,000多名患者， 临床试验每年。 目前，约有105 13个委员会的研究开放供应计。 统计中心是 对癌症研究的设计、实施和分析至关重要 西南肿瘤组的一名医生 其主要职能是（1） 参加对拟议议定书的审查，特别是关于 实验设计、样本量和可行性;（2）提供 所有研究中所有患者的集中登记，以及 （3）在适当的情况下进行随机化;（4）提供审查和质量 控制研究期间收集的数据;（4）提供数据输入 和计算机处理，并存储和检索数据;（5）工作 与小组主席和小组其他调查人员合作， 通过改进形式、更加统一和 可重复的数据定义，以及更经济的数据流，（6） 协助小组主席管理小组;（7）分析 并公布研究结果 （8）使用收集的数据来尝试找到新的 关于预后因素和晚期效应的线索;以及（9）执行 统计研究的有效设计，进行，和分析， 癌症临床试验和癌症控制研究。

The Southwest Oncology Group is a major multi-disease, multi- disciplinary, multi-institution group engaged in cooperative cancer research. This organization now consists of 33 Member Institutions, 21 Community Clinical Oncology Programs (CCOPs), 311 Cooperative Group Outreach Programs (CGOPs), 31 Urologic Cancer Outreach Programs (UCOPs), and 22 high priority affiliates, who together accrue over 6,000 patients to clinical trials each year. Currently there are approximately 105 studies open for accrual in 13 committees. The Statistical Center is essential to the design, conduct, and analysis of the cancer research in the Southwest Oncology Group. Its main functions are (1) to participate in the review of proposed protocols, particularly as regards experimental design, sample size, and feasibility; (2) to provide for central registration of all patients on all studies, and for randomization where appropriate; (3) to provide for review and quality control of data collected during studies; (4) to provide for data entry and computer processing, and storage and retrieval of data; (5) to work with the Group chair and other investigators in the Group to improve the quality of clinical trials through improved forms, more uniform and reproducible data definitions, and more economical flow of data, (6) to help the Group chair in the administration of the Group; (7) to analyze and publish the results of studies in conjunction with the study coordinator; (8) to use the data being collected to try to find new leads regarding prognostic factors and late effects; and (9) to perform statistical research on the efficient design, conduct, and analysis of cancer clinical trials and cancer control research.